[Antidiabetic biguanides]. 1969

M Dérot, and P Pignard, and M Rathery

UI MeSH Term Description Entries
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001645 Biguanides Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. Biguanide

Related Publications

M Dérot, and P Pignard, and M Rathery
May 1983, Journal of pharmaceutical sciences,
M Dérot, and P Pignard, and M Rathery
January 1978, Journees annuelles de diabetologie de l'Hotel-Dieu,
M Dérot, and P Pignard, and M Rathery
August 1997, Revista clinica espanola,
M Dérot, and P Pignard, and M Rathery
December 1964, La Revue du praticien,
M Dérot, and P Pignard, and M Rathery
January 1964, La Presse medicale,
M Dérot, and P Pignard, and M Rathery
January 2003, Biogerontology,
M Dérot, and P Pignard, and M Rathery
December 1961, La Semaine des hopitaux: therapeutique,
M Dérot, and P Pignard, and M Rathery
December 1961, La Semaine des hopitaux: therapeutique,
M Dérot, and P Pignard, and M Rathery
January 1972, Journees annuelles de diabetologie de l'Hotel-Dieu,
M Dérot, and P Pignard, and M Rathery
January 1988, Medicina (Florence, Italy),
Copied contents to your clipboard!